Management of jaundice occurring during antituberculosis chemotherapy.
Carlen
R
R
D000995:Antitubercular Agents / Q000009:adverse effects*; D006801:Humans; D007565:Jaundice / Q000139:chemically induced*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000995:Antitubercular Agents